Manufacturer safeguards may not prevent copayment coupon use for Part D drugs.
- Physical Description: 1 online resource (29 pages) : color illustrations
- Publisher: Washington, DC : Department of Health and Human Services, Office of Inspector General, 2014.
|General Note:|| Title from title screen (viewed June 13, 2016).
|Bibliography, etc. Note:|| Includes bibliographical references.
Search for related items by subject
|Subject:||Medicare > Claims administration.
Pharmaceutical industry > United States.
Nonprescription drug industry > United States.
Copayments (Insurance) > Law and legislation > United States.
Drugs > Prices > United States.